Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

BeOne Medicines - ROA 2014-2025 | ONC

Current and historical return on assets (ROA) values for BeOne Medicines - (ONC) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
  
BeOne Medicines - ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $-0.39B $5.84B -6.73%
2024-12-31 $-0.64B $5.92B -11.14%
2024-09-30 $-0.86B $5.83B -14.95%
2024-06-30 $-0.52B $5.71B -9.23%
2024-03-31 $-0.79B $5.67B -13.82%
2023-12-31 $-0.88B $5.81B -15.33%
2023-09-30 $-0.96B $5.53B -16.26%
2023-06-30 $-1.73B $5.73B -27.95%
2023-03-31 $-1.92B $5.96B -29.00%
2022-12-31 $-2.00B $6.38B -28.12%
2022-09-30 $-2.17B $6.73B -28.24%
2022-06-30 $-2.05B $7.38B -27.99%
2022-03-31 $-1.96B $8.02B -28.63%
2021-12-31 $-1.46B $8.54B -23.17%
2021-09-30 $-1.33B $5.29B -23.84%
2021-06-30 $-1.31B $5.52B -23.31%
2021-03-31 $-1.17B $5.82B -22.34%
2020-12-31 $-1.60B $5.60B -33.38%
2020-09-30 $-1.51B $5.57B -39.93%
2020-06-30 $-1.39B $3.90B -48.64%
2020-03-31 $-1.15B $4.07B -47.17%
2019-12-31 $-0.95B $1.61B -48.57%
2019-09-30 $-0.83B $1.88B -39.23%
2019-06-30 $-0.67B $2.15B -29.66%
2019-03-31 $-0.74B $2.17B -34.74%
2018-12-31 $-0.67B $2.25B -33.61%
2018-09-30 $-0.51B $2.41B -29.63%
2018-06-30 $-0.24B $1.65B -17.88%
2018-03-31 $-0.15B $1.71B -13.84%
2017-12-31 $-0.09B $1.05B -12.76%
2017-09-30 $-0.03B $1.05B -5.72%
2017-06-30 $-0.19B $0.47B -49.60%
2017-03-31 $-0.15B $0.38B -46.65%
2016-12-31 $-0.12B $0.41B -41.14%
2016-09-30 $-0.11B $0.24B -49.77%
2016-03-31 $-0.06B $0.27B -42.47%
2015-12-31 $-0.04B $0.12B -67.98%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $28.024B $3.810B
BeOne Medicines is an oncology company which involved in discovering and developing treatments to cancer patients. BeOne Medicines, formerly known as BeiGene Ltd., is based in SAN CARLOS, Calif.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.319B 28.63
Zoetis (ZTS) United States $70.463B 26.29
Takeda Pharmaceutical (TAK) Japan $48.143B 9.58
Daiichi Sankyo, - (DSNKY) Japan $41.714B 21.38
Sandoz Group AG (SDZNY) Switzerland $24.636B 0.00
Summit Therapeutics (SMMT) United States $18.374B 0.00
Merck (MKKGY) Germany $16.944B 12.41
Shionogi (SGIOY) Japan $14.321B 14.35
United Therapeutics (UTHR) United States $13.557B 11.99
Neurocrine Biosciences (NBIX) United States $13.213B 45.26
Orion OYJ (ORINY) Finland $10.673B 28.86
IPSEN (IPSEY) France $10.299B 0.00
Stevanato Group S.p.A (STVN) Italy $7.650B 46.78
Corcept Therapeutics (CORT) United States $7.518B 61.11
Madrigal Pharmaceuticals (MDGL) United States $6.852B 0.00
Ionis Pharmaceuticals (IONS) United States $6.817B 0.00
Grifols, S.A (GRFS) Spain $6.456B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Soleno Therapeutics (SLNO) United States $4.459B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Hypermarcas (HYPMY) Brazil $3.182B 20.93
Crinetics Pharmaceuticals (CRNX) United States $3.027B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.638B 9.24
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.611B 14.12
NewAmsterdam Pharma (NAMS) Netherlands $2.430B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.896B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.874B 0.00
ARS Pharmaceuticals (SPRY) United States $1.758B 0.00
Ocular Therapeutix (OCUL) United States $1.714B 0.00
Endo (NDOI) United States $1.603B 0.00
Evotec AG (EVO) Germany $1.474B 0.00
Guardian Pharmacy Services (GRDN) United States $1.335B 0.00
ProKidney (PROK) United States $1.270B 0.00
Harrow (HROW) United States $1.161B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.134B 22.68
Ardelyx (ARDX) United States $1.101B 0.00
Enliven Therapeutics (ELVN) United States $1.059B 0.00
Akebia Therapeutics (AKBA) United States $1.048B 0.00
Collegium Pharmaceutical (COLL) United States $1.040B 5.61
Dyne Therapeutics (DYN) United States $1.009B 0.00
Verve Therapeutics (VERV) United States $0.989B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.924B 0.00
Xeris Biopharma Holdings (XERS) United States $0.835B 0.00
Cronos Group (CRON) Canada $0.802B 0.00
KalVista Pharmaceuticals (KALV) United States $0.795B 0.00
Xencor (XNCR) United States $0.664B 0.00
Relay Therapeutics (RLAY) United States $0.653B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.645B 0.00
Zevra Therapeutics (ZVRA) United States $0.632B 0.00
Elite Pharmaceuticals (ELTP) United States $0.610B 0.00
USANA Health Sciences (USNA) United States $0.610B 13.26
Bioventus (BVS) United States $0.601B 15.25
Theravance Biopharma (TBPH) United States $0.580B 0.00
Organogenesis (ORGO) United States $0.566B 0.00
Oruka Therapeutics (ORKA) United States $0.533B 0.00
Siga Technologies (SIGA) United States $0.493B 10.30
Tourmaline Bio (TRML) United States $0.443B 0.00
Savara (SVRA) United States $0.410B 0.00
Aquestive Therapeutics (AQST) United States $0.398B 0.00
Altimmune (ALT) United States $0.384B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.340B 9.20
Heron Therapeutics (HRTX) United States $0.340B 0.00
AleAnna (ANNA) United States $0.322B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 26.83
Nektar Therapeutics (NKTR) United States $0.290B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.282B 0.00
Aldeyra Therapeutics (ALDX) United States $0.271B 0.00
OmniAb (OABI) United States $0.269B 0.00
Nanobiotix S.A (NBTX) France $0.252B 0.00
Esperion Therapeutics (ESPR) United States $0.244B 0.00
MediWound (MDWD) Israel $0.224B 0.00
Larimar Therapeutics (LRMR) United States $0.222B 0.00
China SXT Pharmaceuticals (SXTC) China $0.205B 0.00
4D Molecular Therapeutics (FDMT) United States $0.205B 0.00
Profound Medical (PROF) Canada $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.167B 0.00
Journey Medical (DERM) United States $0.166B 0.00
Lexeo Therapeutics (LXEO) United States $0.153B 0.00
Lyell Immunopharma (LYEL) United States $0.151B 0.00
Inhibikase Therapeutics (IKT) United States $0.150B 0.00
Avita Medical (RCEL) United States $0.149B 0.00
Galectin Therapeutics (GALT) United States $0.142B 0.00
Korro Bio (KRRO) United States $0.138B 0.00
Liminatus Pharma (LIMN) United States $0.136B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.130B 0.00
Protara Therapeutics (TARA) United States $0.124B 0.00
Champions Oncology (CSBR) United States $0.123B 20.25
Cardiol Therapeutics (CRDL) Canada $0.115B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.106B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Nutriband (NTRB) United States $0.091B 0.00
Metagenomi (MGX) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Achieve Life Sciences (ACHV) Canada $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.076B 0.00
Fractyl Health (GUTS) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Inotiv (NOTV) United States $0.073B 0.00
Dominari Holdings (DOMH) United States $0.073B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
Surrozen (SRZN) United States $0.071B 0.00
VAXART, INC (VXRT) United States $0.069B 0.00
Unicycive Therapeutics (UNCY) United States $0.068B 0.00
PMV Pharmaceuticals (PMVP) United States $0.067B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Wellgistics Health (WGRX) United States $0.062B 0.00
ElectroCore (ECOR) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.058B 0.00
Context Therapeutics (CNTX) United States $0.057B 0.00
Century Therapeutics (IPSC) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
Jupiter Neurosciences (JUNS) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 34.28
Klotho Neurosciences (KLTO) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.042B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Vivos Therapeutics (VVOS) United States $0.035B 0.00
Telomir Pharmaceuticals (TELO) United States $0.035B 0.00
Enlivex Therapeutics (ENLV) Israel $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.028B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
FibroGen (FGEN) United States $0.025B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.021B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
BioVie (BIVI) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Ainos (AIMD) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.09
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Talphera (TLPH) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.85
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00